Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to -$11.2 million.

  • Healthequity's Non Operating Income rose 1673.75% to -$11.2 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$47.0 million, marking a year-over-year decrease of 868.74%. This contributed to the annual value of -$46.3 million for FY2025, which is 853.51% down from last year.
  • Per Healthequity's latest filing, its Non Operating Income stood at -$11.2 million for Q4 2025, which was up 1673.75% from -$11.6 million recorded in Q3 2025.
  • Over the past 5 years, Healthequity's Non Operating Income peaked at $245000.0 during Q1 2021, and registered a low of -$16.5 million during Q1 2022.
  • Moreover, its 5-year median value for Non Operating Income was -$11.3 million (2022), whereas its average is -$10.7 million.
  • Per our database at Business Quant, Healthequity's Non Operating Income soared by 10161.73% in 2021 and then plummeted by 684081.63% in 2022.
  • Healthequity's Non Operating Income (Quarter) stood at -$8.8 million in 2021, then crashed by 33.83% to -$11.7 million in 2022, then increased by 16.36% to -$9.8 million in 2023, then tumbled by 36.75% to -$13.4 million in 2024, then rose by 16.74% to -$11.2 million in 2025.
  • Its Non Operating Income stands at -$11.2 million for Q4 2025, versus -$11.6 million for Q3 2025 and -$12.1 million for Q2 2025.